Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics
Brian R. Murphy, Peter L. Collins
Brian R. Murphy, Peter L. Collins
Published July 1, 2002
Citation Information: J Clin Invest. 2002;110(1):21-27. https://doi.org/10.1172/JCI16077.
View: Text | PDF
Perspective

Live-attenuated virus vaccines for respiratory syncytial and parainfluenza viruses: applications of reverse genetics

  • Text
  • PDF
Abstract

Perspective

Authors

Brian R. Murphy, Peter L. Collins

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Map of the RSV genome and spectrum of attenuation exhibited by gene-dele...
Map of the RSV genome and spectrum of attenuation exhibited by gene-deletion viruses. (a) Map of the RSV genome, a single negative-sense RNA of 15.2 kb. Each viral gene is represented by a box, and the gene-start and gene-end transcription signals that flank each gene are indicated by gray and black bars, respectively. The 3′ and 5′ ends of the genome consist of the extragenic leader (Le) and trailer (Tr) regions, respectively. The genes are separated by short intergenic regions except in the case of the M2 and L genes, which overlap but are nonetheless transcribed into separate mRNAs, as are all of the other genes (1). The diagram is only approximately to scale. (b) Mean peak virus titers in the upper (nasopharynx) and lower (tracheal lavage) respiratory tract of chimpanzees that had been inoculated by the intranasal and intratracheal routes simultaneously with the indicated gene-deletion virus or, as controls, with wild-type RSV or with the rRSVcpts248/404 virus. This last virus serves as a reference point for a virus with mild residual virulence for seronegative infants (4).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts